Diagnoses Alzheimer's disease (AD) using revised research diagnostic criteria that integrate clinical phenotypes with pathophysiological biomarkers. The IWG-2 criteria represent a major advancement over previous diagnostic approaches by requiring both an appropriate clinical AD phenotype (typical or atypical) and pathophysiological biomarker evidence of Alzheimer pathology. This framework covers the full disease spectrum from asymptomatic at-risk individuals to typical and atypical AD presentations. The IWG-2 criteria distinguish between pathophysiological markers (CSF Aβ1-42, T-tau, P-tau, amyloid PET) used for diagnosis and topographical markers (volumetric MRI, FDG-PET) used for progression monitoring. This diagnostic tool enables earlier and more accurate identification of AD across the disease continuum, facilitating appropriate treatment planning and research enrollment.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The International Working Group (IWG) 2 Criteria for Alzheimer's Disease Diagnosis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Meets criteria for typical Alzheimer's disease
Meets criteria for atypical Alzheimer's disease
Meets criteria for mixed Alzheimer's disease
Asymptomatic at risk for Alzheimer's disease
Does not meet IWG-2 criteria for AD diagnosis
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.